Skip to main content
. 2019 Dec 5;9:18423. doi: 10.1038/s41598-019-54878-5

Figure 1.

Figure 1

Inhibition of IL-33–induced mast cell activation by resveratrol. (A,B) ELISA of IL-6, IL-13, and TNF-α in culture supernatants of BMMCs (A) and FSMCs (B) treated with resveratrol and exposed to 1 ng/ml rmIL-33 for 6 h (n = 3). (C) ELISA of IL-13 in human peripheral blood basophils treated with resveratrol and exposed to rhIL-33 for 6 h in the presence of rhIL-3 (n = 3). (D) Mice were orally treated with resveratrol for 2 h, and then challenged with intranasal administration of 1 μg IL-33 for 24 h. mRNA expression of IL-6 and IL-13 in the airway was determined by qPCR (n = 4–6). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.